Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2027 (Nomination deadline)
Funding Amounts: Scientific achievement award; monetary amount not specified
Summary: Recognizes excellent original research by established investigators in cancer pharmacology.
Key Information: Nominees must be established investigators and ASPET members.
The Susan B. Horwitz Award Lecture in Cancer Pharmacology is a division-sponsored scientific achievement award offered by the American Society for Pharmacology and Experimental Therapeutics (ASPET). Established by its Division for Cancer Pharmacology, the award recognizes excellent original research by established investigators in cancer pharmacology. Its focus is recognition of scientific contributions rather than funding a proposed research project.
The award honors Dr. Susan Band Horwitz, a pioneer in understanding the mechanisms of action of cancer chemotherapy drugs. Her work changed the nature of cancer treatment, and many of the drugs she studied remain mainstays of cancer therapy. The award sits within ASPET’s broader division-sponsored awards program, which recognizes excellence in specific areas of pharmacology.